ENTER Conference 2021

in conjunction with

The LVR Hospital Essen and the University of Duisberg-Essen, Germany

Date: 15th September 2021

 

Conference Theme

Current developments in the care of persons with substance-related disorders: An update on interventions in substance use 2021

 

ENTER held its annual conference online on the 15th Septembr 2021 in conjunction with the LDV Hospital in Essen and the University of Duisberg-Essen.  The conference theme centred on developments over the last 30 years, in the care of people experiencing substance related disorder.  It was introduced by  by Prof. Marja Kaunonen (ENTER) & Prof. Dr. N. Scherbaum (LVR).  

 

The conference featured keynote addresses by Prof. Dr. Norbert Scherbaum, University of Duisburg-Essen, Germany on “Addiction medicine – The last 30 years and future developments”“NPS, psychonauts; and psychopharmacology“ by Prof. Dr. Fabrizio Schifano, University of Hertfordshire, United Kingdom“Computer-based trainings as an add-on to addiction treatment: Where are we, what remains to be done?” by Prof. Dr. Mike Rinck, Radboud University, Nijmegen, Netherlands and “Neurocognitive impairments in chronic opioid users” by Prof. Alex Baldacchino, University of St. Andrews, Scotland.  We plan to host videos of these presentations on the website shortly.  

 

The conference also featured presentations in the parallel sessions on novel interventions, epidemiology and intervention and user experiences.  Videos of the keynote presentations presentations are below, and the presentations from the parallel sessions will be posted here shortly.

Introduction to the ENTER Conference 2021

Prof Marja Kaunonen

Keynote presentations
  1. Prof Norbert Scherbaum discusses addiction medicine in the past 30 years and aspects which may need to be considered in the future.

  2. Prof Fabrizio Schifano discusses NPS, Psychonauts and psychopharmacology.

  3. Prof Mike Rinck discusses the use of computer based training in addiction treatment.

  4. Prof Alex Baldacchino discusses opioid addiction.